Laryngeal cancer secondary prevention

	Laryngeal cancer Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Laryngeal cancer from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Staging
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Laryngeal cancer secondary prevention On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Laryngeal cancer secondary prevention All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Laryngeal cancer secondary prevention
CDC on Laryngeal cancer secondary prevention
Laryngeal cancer secondary prevention in the news
Blogs on Laryngeal cancer secondary prevention
Directions to Hospitals Treating Laryngeal cancer
Risk calculators and risk factors for Laryngeal cancer secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Faizan Sheraz, M.D. [2]

Overview

Secondary prevention measures of laryngeal cancer include routine physical examination and imaging at scheduled intervals after treatment. Dental screening and screening for thyroid cancers are recommended among patients who had received radiation therapy to the oral cavity and cervical region, respectively.

Patients treated for laryngeal carcinoma should follow-up for secondary prevention. Follow-up measures are shown in the table below:^[1]


Follow up	Description

Physical exam	Every 1-3 months during the 1st year after treatment Every 2-6 months during the 2nd year after treatment Every 4-8 months between the 3rd and 5th years after treatment Annually thereafter
Nasendoscopy	Immediately following radiation therapy
CT Scan/MRI	Imaging studies are performed at routine intervals as follows: Baseline scanning is performed at 3-6 months after treatment, further scans are scheduled based on finding of physical exam and symptoms experienced by the patient Scanning for asymptomatic patients is not recommended
Thyroid hormone testing	Thyroid stimulating hormone testing every 12 months if the neck was exposed to radiation
Dental screening	Only recommended if oral cavity was exposed to radiation

↑ Pfister DG, Ang KK, Brizel DM, Burtness BA, Busse PM, Caudell JJ; et al. (2013). "Head and neck cancers, version 2.2013. Featured updates to the NCCN guidelines". J Natl Compr Canc Netw. 11 (8): 917–23. PMID 23946171.